Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, signaling a newer version of the page. This update does not change the study details or the information presented to users.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:09.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a minor page revision.
    Difference
    0.0%
    Check dated 2026-04-30T16:40:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the prior revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:34:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:16:08.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:25:59.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is added as a resources entry for gastric cancer.
    Difference
    0.1%
    Check dated 2026-02-18T07:29:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.